global cardiac biomarkers market 2014-2018
DESCRIPTION
A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. TechNavio's analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.TRANSCRIPT
Global Cardiac Biomarkers Market 2014-2018
TechNavio Insights
USA – CANADA – UK – CHINA – INDIA
Market Overview: Cardiac Biomarkers
About Cardiac Biomarkers • A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification
related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure.
• Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L.
• Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs.
• Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing.
• In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error.
• TechNavio's analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.
USA – CANADA – UK – CHINA – INDIA
Covered in This Report
• This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018.
• To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases.
• The market is segmented based on the following type of assay: • Troponin (cTnI and cTnT) • BNP & NT-proBNP • CK-MB • Myogloblin • Others (hs-CRP, D-Dimer, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, AST, FFAu, and sCD40L)
• TechNavio's report, the Global Cardiac Biomarkers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.
• The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cardiac Biomarkers market landscape and its growth prospects in the coming years.
• The report includes a discussion of the key vendors operating in this market.
USA – CANADA – UK – CHINA – INDIA
Key Regions
Americas
EMEA
APAC
USA – CANADA – UK – CHINA – INDIA
Key Vendors
Key Vendors• Abbott Laboratories• Alere• Ortho Clinical Diagnostics• Roche Diagnostics
Other Prominent Vendors• AniBiotech• Axis-Shield• Beckman Coulter• Becton, Dickinson and Co.• BG Medicine• Biomerieux• Boston Scientific• Critical Diagnostics• diaDexus• LifeSign• Mitsubishi Chemical Europe• Nanomix• Radiometer Medical
USA – CANADA – UK – CHINA – INDIA
Market Drivers, Challenges and Trends
Guest BloggersDriver• Growing Incidence of Cardiac Disorders.• For a full, detailed list, view our report.
Challenge• Lack of Specific Measures to Detect Presence of
CVDs.• For a full, detailed list, view our report.
Trend
• Identification of New Cardiac Biomarkers.• For a full, detailed list, view our report.
A detailed analysis of each market driver, challenge and trend is
available in our report:
Global Cardiac Biomarkers Market 2014-2018
USA – CANADA – UK – CHINA – INDIA
Key Questions
Questions Answered in Our Report
• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key
vendors?• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
USA – CANADA – UK – CHINA – INDIA
View Our Report
Global Cardiac Biomarkers Market 2014-2018
View Report >>
TechNavio's report, Global Cardiac Biomarkers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.
Published on: November 05, 2014 | 101 Pages | SKU: IRTNTR4572
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
Mail us at: [email protected]
You can visit us at:www.technavio.com
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of
or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION